| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |